Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Change in Receivables: 2010-2024

Historic Change in Receivables for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $2.0 million.

  • Cryo Cell International's Change in Receivables fell 2121.57% to $315517.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $478581.0, marking a year-over-year decrease of 7108.8%. This contributed to the annual value of $2.0 million for FY2024, which is 2747.96% up from last year.
  • Cryo Cell International's Change in Receivables amounted to $2.0 million in FY2024, which was up 2747.96% from $1.6 million recorded in FY2023.
  • Cryo Cell International's 5-year Change in Receivables high stood at $2.0 million for FY2024, and its period low was -$532788.0 during FY2021.
  • Moreover, its 5-year median value for Change in Receivables was $1.6 million (2023), whereas its average is $1.1 million.
  • In the last 5 years, Cryo Cell International's Change in Receivables crashed by 16430.02% in 2021 and then surged by 42290.25% in 2022.
  • Annual analysis of 5 years shows Cryo Cell International's Change in Receivables stood at $828594.0 in 2020, then plummeted by 164.3% to -$532788.0 in 2021, then soared by 422.9% to $1.7 million in 2022, then decreased by 8.82% to $1.6 million in 2023, then grew by 27.48% to $2.0 million in 2024.
  • Its Change in Receivables was $2.0 million in FY2024, compared to $1.6 million in FY2023 and $1.7 million in FY2022.